Site Editor

Karl D. Lewis, MD

Advertisement

Advertisement

Medical Literature

Skin Cancer Following Solid Organ Transplantation and Transcribed HPV Infection

News

ESMO 2021: Final Results of Phase II Trial of First-Line Nivolumab in Squamous Cell Carcinoma

News

ESMO 2021: Extended-Dose Cemiplimab-rwlc Under Study in Squamous Cell Carcinoma

Medical Literature

Avelumab in Electrochemotherapy-Resistant Merkel Cell Carcinoma: Case Report

News

Link Between Cutaneous HPV and Squamous Cell Skin Cancer?

Medical Literature

Measuring the Burden of Skin Cancers in the United States: From 1990 to 2019

JNCCN Spotlights

(UPDATE) Cemiplimab in Cutaneous Squamous Cell Carcinoma

Francis P. Worden, MD, on Vismodegib: Organ Preservation for Orbital/Periocular Basal Cell Carcinoma

Steven M. Horwitz, MD, on PTCL and CTCL: Trial Results on Cerdulatinib, a Dual SYK/JAK Inhibitor

View More

Advertisement

JNCCN Spotlights

Cetuximab (Erbitux®) – (Non-Melanoma Skin Cancers)

Avelumab (Bavencio)

(UPDATE) Cemiplimab in Cutaneous Squamous Cell Carcinoma

View More

More

News

Link Between Cutaneous HPV and Squamous Cell Skin Cancer?

Combination Checkpoint Antibody Treatment in Cutaneous Squamous Cell Carcinoma

Are American Adults Taking Skin Cancer Seriously? Survey Findings Suggest Perhaps Not

ASCO 2021: Combination of HDAC Inhibitor and Pembrolizumab in Advanced Skin Cancer

Topical Remetinostat Under Study in Basal Cell Carcinoma

Trends in Skin Cancers: Findings From Global Burden of Disease Study

Exclusive Radiotherapy: Potential Alternative to Surgery for Merkel Cell Carcinoma?

Intraoperative Fluorescent Imaging Agent Under Study in Patients With Skin Cancer

View More

Advertisement

Published

Medical Literature

Potential Biomarker Investigated for Merkel Cell Carcinoma

Japanese Study Explores Risk Factors for Non-Melanoma Skin Cancer

Case Study: Basal Cell Carcinoma as a Nonhealing Lesion

Case Study: Malignant Melanoma After Merkel Cell Carcinoma

View More

Ongoing

CE Activities

The Role Of PD-1 Inhibitors in The Evolving Landscape of Advanced Cutaneous Squamous Cell Carcinoma Treatment

A Multidisciplinary Approach to Individualized Patient Care: Non-Melanoma Skin Cancer

No Elevated Cancer Risk for RA Patients With Tocilizumab

Could AI Trained to ID Skin Cancer Attain Accuracy of Dermatologists?

View More

Available

Clinical Trials

University of Nebraska

Seidman Cancer Center

Dana-Farber Cancer Institute

Duke Cancer Institute

View More

Resources

For Your Patients

American Academy of Dermatology

CancerCare

The Skin Cancer Foundation

Cancer.Net

View More

Sections

360 Hub

NCCN Resources

Copyright^© 2021 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.